SPANO, Maria Carlotta
 Distribuzione geografica
Continente #
NA - Nord America 4.921
EU - Europa 4.248
AS - Asia 2.464
SA - Sud America 353
AF - Africa 57
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.060
Nazione #
US - Stati Uniti d'America 4.815
SE - Svezia 1.972
SG - Singapore 822
IT - Italia 797
CN - Cina 643
GB - Regno Unito 601
VN - Vietnam 288
HK - Hong Kong 285
BR - Brasile 260
DE - Germania 240
RU - Federazione Russa 124
FR - Francia 100
UA - Ucraina 80
FI - Finlandia 79
KR - Corea 68
TR - Turchia 62
IN - India 57
MX - Messico 44
CA - Canada 41
ID - Indonesia 41
BE - Belgio 40
NL - Olanda 39
AR - Argentina 32
BG - Bulgaria 30
BD - Bangladesh 28
JP - Giappone 27
IE - Irlanda 25
ES - Italia 22
PL - Polonia 21
AL - Albania 20
IQ - Iraq 18
ZA - Sudafrica 18
AE - Emirati Arabi Uniti 16
PK - Pakistan 16
EC - Ecuador 15
AU - Australia 14
CL - Cile 12
CO - Colombia 12
UZ - Uzbekistan 12
MY - Malesia 9
VE - Venezuela 9
AT - Austria 8
CZ - Repubblica Ceca 8
JO - Giordania 8
PE - Perù 8
MA - Marocco 7
SA - Arabia Saudita 7
SI - Slovenia 7
PT - Portogallo 6
RO - Romania 6
AZ - Azerbaigian 5
DZ - Algeria 5
PH - Filippine 5
SN - Senegal 5
TN - Tunisia 5
BZ - Belize 4
IL - Israele 4
KE - Kenya 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NP - Nepal 4
OM - Oman 4
BB - Barbados 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EG - Egitto 3
JM - Giamaica 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
MN - Mongolia 3
PS - Palestinian Territory 3
RS - Serbia 3
TW - Taiwan 3
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
HU - Ungheria 2
IR - Iran 2
KH - Cambogia 2
MK - Macedonia 2
PA - Panama 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
Totale 12.043
Città #
Stockholm 1.775
Singapore 555
Ashburn 553
Fairfield 428
Santa Clara 422
Southend 363
Hong Kong 272
Chandler 238
Woodbridge 225
Ann Arbor 221
San Jose 214
Hefei 198
Houston 198
Seattle 180
Wilmington 167
Cambridge 132
Beijing 120
Dearborn 119
Jacksonville 109
Modena 107
Chicago 106
Nyköping 105
Los Angeles 102
London 92
Bologna 91
Ho Chi Minh City 89
Hanoi 86
New York 77
Council Bluffs 75
Milan 67
Munich 64
Seoul 63
The Dalles 54
Helsinki 51
Frankfurt am Main 47
Brussels 37
Lauterbourg 32
Moscow 32
Fremont 31
Izmir 31
Jakarta 31
Shanghai 30
San Diego 29
Orem 26
Sofia 26
Boardman 25
Dallas 25
Princeton 25
Dublin 24
Salt Lake City 24
São Paulo 23
Buffalo 22
Eugene 22
Tampa 22
Parma 19
Phoenix 19
Rome 19
Elk Grove Village 18
Lancaster 18
Tokyo 18
Bremen 17
Reggio Emilia 16
San Giuliano Milanese 16
Columbus 15
Denver 15
Des Moines 15
Falls Church 15
Florence 15
Guangzhou 15
Mexico City 15
Tirana 15
Nuremberg 14
Redwood City 14
Warsaw 14
Amsterdam 13
Chennai 13
Atlanta 12
Da Nang 12
Haiphong 12
Montreal 12
Manchester 11
Brooklyn 10
Genoa 10
Ravenna 10
Redondo Beach 10
Hillsboro 9
Tashkent 9
Adelaide 8
Dulles 8
Johannesburg 8
Ottawa 8
Portsmouth 8
Quito 8
Romola 8
Turku 8
Vienna 8
Amman 7
Baghdad 7
Casalecchio Di Reno 7
Ferrara 7
Totale 8.847
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.194
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 458
GD2 expression in breast cancer. 419
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 419
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 413
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 392
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 384
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 380
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus 362
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 360
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 347
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM 331
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria 328
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 318
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation 312
Detection of microparticles from human red blood cells by multiparametric flow cytometry 303
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 291
Donor Cell-Derived Osteopoiesis Originates from a Self-Renewing Stem Cell with a Limited Regenerative Contribution after Transplantation 285
An adoptive immuno-gene therapy approach targeting neuroblastoma. 278
The phenotypes of microglia and macrophages during epileptogenesis 274
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 272
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors 257
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma 240
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 236
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 234
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 229
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 204
CELLULE STAMINALI: REALTA’ E PROSPETTIVE 199
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 194
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 183
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 179
Una cellula effettrice modificata per il trattamento di neoplasie esprimenti il disialonganglioside GD2 175
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 165
Abstract A17: Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study 161
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 146
Targeting pancreatic ductal adenocarcinoma & its stroma by a chemo & gene therapy strategy 139
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 120
Totale 12.181
Categoria #
all - tutte 37.544
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.544


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 0 0 0 0 0 92 30
2021/2022777 17 84 101 41 33 31 66 64 66 49 149 76
2022/2023763 100 87 48 90 87 100 12 73 91 7 47 21
2023/2024474 33 26 44 43 76 41 44 60 7 17 21 62
2024/20252.138 51 43 100 167 319 342 225 109 233 100 168 281
2025/20265.371 292 145 299 495 772 195 454 154 2.114 388 63 0
Totale 12.181